Fig. 4From: Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world studyKaplan–Meier curves of disease-free survival for the high-risk group (A) and low-risk group (B) stratified on CC-CCD levels (< 160 mg/m2 vs. ≥ 160 mg/m2). CC-CCD cumulative cisplatin dose during concurrent chemoradiotherapyBack to article page